Sunday, March 20, 2011

PT presentation tomorrow

Case Presentation Schedule

Pharmacotherapeutics II & Clinical Pharmacy II

Date: March 21, 2011

Time: 2:00 pm – 5:00 pm

Venue 1: Lecture Hall Year 3

Time

Group

Case titles

2:00 – 2:15 pm

B1

Schizophrenia with multiple bone fractures

2:16 – 2:30 pm

B3

Epilepsy

2:31 – 2:45 pm

C1

Active TB with dehydration 2 to poor oral intake

2:46 – 3:00 pm

D3

PCP

3:01 – 3:15 pm

E2

Schizophrenia

3:16 – 3:30 pm

A1

Advanced breast cancer

3:31 – 3:45 pm

C6

HIV with multiple infections

3:46 – 4:00 pm

E4

Seizure

4:01 – 4:15 pm

A6

Meningitis

4:16 – 4:30 pm

A3

DM with CKD stage 4

4:31 – 4:45 pm

D6

Relapse schizophrenia

4:46 – 4:00 pm

B2

Major depressive disorder

4:01 – 4:15 pm

A5

Pulmonary tuberculosis

4:16 – 4:30 pm

C4

Hospital-acquired pneumonia with septic arthritis

4:31 – 4:45 pm

D4

Schizophrenia

Final comments by evaluators

Evaluators/Assessors

1. Dr. Zainol Akbar bin Zainal

2. Mdm. Hjh. Rohani bt. Mat Nor

3. Mdm. Siti Halimah Bux bt. Shaikh Rahman Bux

4. Br. Mohd. Hafiz b. Abdul Aziz


Case Presentation Schedule

Pharmacotherapeutics II & Clinical Pharmacy II

Date: March 21, 2011

Time: 2:00 pm – 5:00 pm

Venue 2: Lecture Hall Year 4

Time

Group

Case titles

2:00 – 2:15 pm

E1

Relapse schizophrenia

2:16 – 2:30 pm

B5

Epilepsy

2:31 – 2:45 pm

D1

Hemoptysis 2 to TB

2:46 – 3:00 pm

C2

PCP 2 to pulmonary TB

3:01 – 3:15 pm

E3

Schizophrenia

3:16 – 3:30 pm

A2

Rectosigmoid cancer

3:31 – 3:45 pm

D5

TB secondary to HIV infection

3:46 – 4:00 pm

B4

Neonatal seizure

4:01 – 4:15 pm

A4

Melioidosis

4:16 – 4:30 pm

D2

Hypoglycemia 2to CAP

4:31 – 4:45 pm

E6

Relapse schizophrenia

4:46 – 4:00 pm

B6

Drug-induced psychosis

4:01 – 4:15 pm

C3

Meningococcal tuberculosis

4:16 – 4:30 pm

C5

AECOPD 2 to CAP

4:31 – 4:45 pm

E5

Schizophrenia

Final comments by evaluators

Evaluators/Assessors

1. Dr. Che Suraya bt. Mat Zin

2. Mdm. Nurdiana bt. Jamil

3. Mdm. Nurul Azrin bt Abdul Rahman

4. Dr. Qais Mohammad Ahmad Al-Efan.

No comments: